A new strategy to keep workers on the job after injury or illness

NCT ID NCT05173350

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study tests whether a package of services—including medical provider support, return-to-work coordination, assistive technology, and peer support—can help Kentucky workers who are at risk of leaving the workforce due to a non-work-related injury or illness. Participants are employed or recently employed adults who have not applied for federal disability benefits in the past five years. The trial compares those receiving the full set of services to those who do not, measuring employment rates, earnings, and disability benefit applications over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A combination of medical provider services, return-to-work coordination, assistive technology, peer support, and financial incentives for healthcare professionals.
What this could lead to
If successful, this approach could help many workers recover and keep their jobs, reducing reliance on disability benefits and improving quality of life.
What could go wrong
The trial is large but results depend on real-world implementation, and outcomes may vary by individual circumstances. There are no major medical risks, but the intervention may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISABILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Human Development Institute, University of Kentucky

    Lexington, Kentucky, 40506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.